Condition

Mucosal Melanoma clinical trials and research

• 7Clinical trials
• 8Countries

Newest Mucosal Melanoma clinical trials

All recruiting trials (7)

• First-in-human test of KUP-101A in selected advanced skin cancers

  This early study tests KUP-101A to see if it's safe and tolerable and to gather initial clues about its activity in patients with advanced skin cancers.

  Recruiting at 3 sites Phase 1 Kupando GmbH · Munich, Bavaria and 2 other locations · NCT07600476

• Sintilimab plus chemotherapy after surgery for mucosal melanoma

  This test will see if adding the immunotherapy drug sintilimab to standard chemotherapy after surgery helps people with PD-L1–positive mucosal melanoma stay cancer-free longer.

  Recruiting Phase 2 The First Hospital of Jilin University · Changchun, Jilin · NCT07400302

• Neoadjuvant intratumoral ipilimumab plus nivolumab for resectable stage III melanoma

  This trial tests whether injecting ipilimumab and nivolumab directly into tumors before surgery helps adults with resectable stage III cutaneous or mucosal melanoma.

  Recruiting at 6 sites Phase 2 Unicancer · Bordeaux and 5 other locations · NCT07230613

• Neoadjuvant ipilimumab, relatlimab, and nivolumab combinations for resectable cutaneous and mucosal melanoma

  This phase 2 trial will test several immunotherapy combinations given before surgery to try to reduce recurrence in adults with resectable stage 3 cutaneous melanoma or resectable mucosal melanoma, including patients predicted or known to respond poorly to standard anti‑PD‑1 therapy.

  Recruiting Phase 2 Melanoma Institute Australia · Wollstonecraft, New South Wales · NCT06999980

• Comparing IMA203 treatment to standard options for advanced melanoma

  This study is testing a new treatment called IMA203 to see if it works better than standard options for people with advanced melanoma who can't have surgery.

  Recruiting at 71 sites Phase 3 Immatics US, Inc. · Phoenix, Arizona and 70 other locations · NCT06743126

• Detecting and clearing residual disease in high-risk melanoma patients

  This study is testing if a new combination treatment for high-risk melanoma can help patients with leftover cancer cells in their blood feel better compared to the usual treatment.

  Recruiting Phase 2 University Health Network, Toronto · Toronto, Ontario · NCT06319196

• Combining axitinib and nivolumab for treating advanced mucosal melanoma

  This study is testing if a new combination of two cancer drugs, axitinib and nivolumab, can help people with advanced mucosal melanoma who haven't had treatment before feel better and live longer.

  Recruiting at 2 sites Phase 2 Memorial Sloan Kettering Cancer Center · Harrison, New York and 1 other locations · NCT05384496

Related topics

Quick answers

How many Mucosal Melanoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in Canada (2 trials), France (2 trials), Germany (2 trials), United States (2 trials), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →